Apoptosis in Chronic Myelogenous Leukemia: Studies of Stage-Specific Differences

References

• Clarkson B., Strife A. Discordant maturation in chronic myelogenous leukemia. Chronic myelogenous leukemia. Molecular approaches to research and therapy, A. B. Deisseroth, R. B. Arlinghaus. Marcel Dekker, New York, NY 1991; 3, 1991
   Google Scholar
• Stryckmanns P. A., Debusscher L., Collard E. Cell kinetics in chronic granulocytic leukaemia (CGL). Clin. Haematol. 1977; 6: 21
   PubMedGoogle Scholar
• Clarkson B., Strife A. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia 1993; 7: 1683
   PubMed Web of Science ®Google Scholar
• McGahon A., Bissonette R., Schmitt M., Cotter K. M., Green D. R., Cotter T. G. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994; 83: 1179
   PubMed Web of Science ®Google Scholar
• Bedi A., Zehnbauer B. A., Barber J. P., Sharkis S. J., Jones R. J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038
   PubMed Web of Science ®Google Scholar
• Wetzler M., Talpaz M., VanEtten R. A., Hirsch-Ginsberg C., Beran M., Kurzrock R. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest. 1993; 92: 1925
   PubMed Web of Science ®Google Scholar
• Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16
   PubMed Web of Science ®Google Scholar
• Klein H., Becher R., Lbbert M., Oster W., Schleiermacher E., Brach M. A., Souza L., Lindemann A., Mertelsmann R. H., Herrmann F. Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia. J. Exp. Med 1990; 171: 1785
   PubMed Web of Science ®Google Scholar
• Silver R. T., Gale R. P. Chronic myeloid leukemia. Am. J. Med. 1986; 80: 1137
   PubMed Web of Science ®Google Scholar
• Wetzler M. R., Kurzrock, Estrov Z., Kantarjian H., Gisslinger H., Underbrink M. P., Talpaz M. Altered levels of interleukin-1β and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. Blood 1994; 84: 3142
   PubMed Web of Science ®Google Scholar
• Brach M. A., DeVos S., Gruss H. J., Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992; 80: 2920
   PubMed Web of Science ®Google Scholar
• Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992; 80: 2012
   PubMed Web of Science ®Google Scholar
• Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochemistry 1956; 62: 20
   Google Scholar
• Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239
   PubMed Web of Science ®Google Scholar
• Ahmed S. A., Gogal R. M., Walsh J. E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to H3—thymidine incorporation assay. J. Immunol. Method, (in press)
   Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Arlin Z., Advani S., Allen S. L., Goldman J., Snyder D., Foti A., Cline M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 1991; 87: 2042
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl. Acad. Sci. USA 1988; 85: 9312
   PubMed Web of Science ®Google Scholar
• Imamura J., Miyoshi I., Koeffler H. P. p53 in hematologic malignancies. Blood. 1994; 84: 2412
   PubMed Web of Science ®Google Scholar
• Sirard C., Laneuville P., Dick J. E. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood. 1994; 83: 1575
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cimadevilla J. C., Beauchemin V., Villeneuve L., Letendre F., Shaw A., Hoang T. Coordinate secretion of interleukin-1β and granuloyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer. Blood. 1990; 76: 1481
   PubMed Web of Science ®Google Scholar
• Muroshi I., Tohuda S., Suzuki T., Nagata K., Yamashita Y., Nara N. Mechanism of action of interleukin-1 on the progenitors of blast cells in acute myeloblastic leukemia. Exp. Hematol. 1990; 18: 133
   PubMed Web of Science ®Google Scholar
• Armaout M. A., Wang E. A., Clark S. C., Sieff C. A. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J. Clin. Invest. 1986; 78: 597
   PubMed Web of Science ®Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman J. M., Greaves M. F. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukaemia. Nature. 1987; 328: 342
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M., McCarthy J. B., McGlave P. B. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J. Clin. Invest. 1992; 90: 1232
   PubMed Web of Science ®Google Scholar
• Wintrobe M. M. Clinical Hematology. Lea & Febiger, Philadelphia 1981; 192
   Google Scholar